Introduction {#Sec1}
============

This technique may reinforce and augment internal plate fixation in displaced proximal humeral factures (PHF) with an unstable medial hinge, especially in weak and osteoporotic bone with substantial loss of the structural bony scaffold. Compared to conventional plate fixation methods, it may not only decisively increase bony stability and prevent secondary fracture displacement, but also allow for full initial range of motion (ROM) \[[@CR1]\].

Surgical principles and objective {#Sec2}
=================================

To augment surgical fixation and to achieve postoperative stability strong enough to initially start full ROM and to prevent secondary displacement in unstable fracture patterns and/or weak and osteoporotic bone.

Advantages {#Sec3}
==========

Joint preserving method without artificial materialIncreased stability after open reduction and internal plate fixation of PHFAnatomic reduction in cases of substantial bone loss using a biological structural void fillerStrong structural bony congruencyNo additional surgical approach, wound site, or donor morbidityAverage technical skills demandedInitial full weightbearing and ROMPotential prevention of secondary postoperative fracture displacementVery low infection rates or graft-versus-host reactions \[[@CR1], [@CR3]\]Solid bone stock for potential secondary prosthetic interventions

Disadvantages {#Sec4}
=============

Allogenic bony materialPotential risk of infection, transmission of diseases and graft-versus-host reactionMinimal risk of nonunionMinimally increased operation timeLimited accessibility to allograftsIncreased costs if not derived by in-house bony banks

Indications {#Sec5}
===========

(Secondarily) displaced 2‑part proximal humerus fractures (PHF) with an unstable medial hinge and substantial bony deficiencyCases of weak and osteoporotic bony structureIncreased risk for secondary displacement due to pre-existing psychiatric illnesses or patient incompliance to obey rules \[[@CR2], [@CR5]\]

Contraindications {#Sec6}
=================

Open or contaminated fracturesSystemic immunodeficiencyRunning systemic chemotherapyPrior graft-versus-host reaction

Patient information {#Sec7}
===================

The following risks are possible:Contamination/transmission of diseases \[[@CR3]\]Graft-versus-host reaction, systemic host rejectionImplant failure (screw perforation, loosening, breakage, or intolerance)NonunionBony dissolution over timeDisintegration and secondary displacementRe-operationInfection, thrombosis, embolism, vascular or nerve damage

Preoperative work up {#Sec8}
====================

Bilateral shoulder CT and 3D reconstruction to distinctively assess the grade of displacement and/or the size of the bony defectPre-order (in-house bank or third party) of an appropriately sized bony allograft (at least one half of a femoral head)Femoral heads seem to be rather nonosteoporotic if derived from a replacement surgery of an arthritic hipThe allograft should be fresh frozen and test negatively for transmittal diseases, contamination, and infection, no antibiotic treatment or preserving processing to the graft prior to implantationThawing of the fresh frozen graft to room temperature at least 1 h prior to surgeryShaving of the complete shoulder region, including axillaSingle shot intravenous antibiotic administration (bone consistently, at least 30 min prior to the skin cut, i. e., aminopenicillin) \[[@CR4]\]

Instruments {#Sec9}
===========

Bone saw to decorticate the allograftLuer-like instruments (Rangeur)

Anesthesia and positioning {#Sec10}
==========================

General anesthesiaInterscalene block (beneficial and recommended, but not mandatory)Supine position and mild angulation of the upper body (approximately 20°; Fig. [1](#Fig1){ref-type="fig"})Positioning on the edge of the table with the arm freely movable on an optional adjustable table (Fig. [2](#Fig2){ref-type="fig"})Regular prepping and wrappingFig. 1Supine positioning of the patient with the upper body elevated by approximately 20° and the shoulder extending from the table's edge, allowing the surgeon free manipulationFig. 2Positioning of the optional mobile arm table (soft surface and edges), adjustable in height and freely movable

Surgical technique {#Sec11}
==================

(Figs. [3](#Fig3){ref-type="fig"}, [4](#Fig4){ref-type="fig"}, [5](#Fig5){ref-type="fig"}, [6](#Fig6){ref-type="fig"}, [7](#Fig7){ref-type="fig"}, [8](#Fig8){ref-type="fig"}, [9](#Fig9){ref-type="fig"}, [10](#Fig10){ref-type="fig"}, [11](#Fig11){ref-type="fig"}, [12](#Fig12){ref-type="fig"}, [13](#Fig13){ref-type="fig"}, [14](#Fig14){ref-type="fig"}**,**[15](#Fig15){ref-type="fig"}**, **[16](#Fig16){ref-type="fig"}, [17](#Fig17){ref-type="fig"})Fig. 3Surgical approach. Deltopectoral approach, 10--12 cm in length. The incision starts distally to the coracoid, continuing distally towards the ventral humerus, orienting just above the medial border of the deltoid muscle, lateral to the axilla. The subcutaneous fatty tissue is then cut to expose the deltopectoral fascia underneathFig. 4Deep deltopectoral approach. Sharp or blunt skin retractors should be used to display the surgical situs. The cephalic vein is then identified underneath the fascia (*white arrows*), dividing the deltoid muscle laterally, and the pectoralis major muscle medially. Prepping to its medial site, the vein is held laterally, still attached to the deltoid muscle. *White asterisk* indicates the deltoidFig. 5Fracture situs. Identifying the coracoid in the depth, careful blunt division of deltoid and pectoralis major muscles is performed from proximal to distal. Originating from the coracoid, the conjoint tendon may now be identified and retraced medially to display the fracture situs (a four-part fracture of the proximal humerus is shown in the drawing). Special care should be taken not to harm the axillary nerveFig. 6Identification of the rotator cuff. Prior to the reduction of the fracture, the functional components of the rotator cuff have to be identified and looped. Anatomically, the long head of the biceps tendon (LHB) and its bicipital groove on the humerus divides the lesser tuberosity (anterior part of the rotator cuff, subscapularis tendon) from the greater tuberosity (lateroposterior part of the rotator cuff, supraspinatus (SSP) and infraspinatus tendons). Stay sutures at the tendon bone interface are placed to be able to gently manipulate the fragments. Usually, the fracture line between the tuberosities runs about 8--10 mm posterior to the bicipital groove. In cases of four-part fractures, or whenever sutures are crossing the sulcus, the LHB is identified and cut above the pectoralis major's tendon and sutured to the tendon. Any intertuberosity fracture is followed to the SSP, which is split longitudinally to entry the joint. The proximal portion of the LHB is cut at its origin on the superior glenoid and removed. In case of any three-part fracture (greater tuberosity involved) without a fracture of the bicipital groove, the LHB is not treated at allFig. 7Disimpaction and reduction of the fracture, preparation of the situs. All three functional components of the rotator cuff are looped to later easily close the cuff and secure it to the plate. Fracture displacement and impaction may now be reduced and the fracture is "opened". Manipulating the elbow, mildly rotating and pulling the shaft component may help to properly reduce the fracture and to align the fracture components. Drawing of the partially "opened" fracture situs. The LHB is followed medially and cut at its origin using a scissorsFig. 8Preparation of the allograft. Any soft tissue or articular cartilage is dissected off the allograft using a saw. To allow for secure positioning within the distal shaft component and to serve as a scaffold with the largest possible surface for the head fragment at the same time, the graft is shaped like a "mushroom" or "Champaign plug". **a** Fresh frozen partial femoral neck (*left*) and head (*right*) allografts. **b** Dissection of the allograft (off patient). **c,** **d** Pretreated allograft with all cartilage dissectedFig. 9Detailed graft preparation. In the ideal case of a femoral head allograft, the femoral neck may represent the mushroom's stem, and the femoral head may represent the carrying surface component. Ideally, the dense subchondral zone of the femoral head is preserved to build the strong mushroom's "hat". The graft is oversized with approximately 30 mm in width and height. However, individual tailoring of the allograft is necessary. In order to allow easy removal, which will be necessary to exactly shape the graft for the individual defect's size, No. 1 Vicryl is used to loop and secure the graft around its neck. **a,** **b,** **c,** **d** "Mushroom"-shaped allograft, approximately 30 mm in width and height. **d** Looped and secured using No. 1 VicrylFig. 10"Allografting". The graft is then implanted into the fracture situs, with its stem (*dashed line*) facing the humeral shaft, and its roof filling the hollow humeral head. Using Luer forceps, the graft is adjusted. This step is crucial, since the allograft has to be removed several times to perfectly tailor it to the individual fracture and defect site without breaking itFig. 11Fracture "closure". Once the allograft fits macroscopically, the head and the tuberosities are reduced using No. 1 Vicryl wires. A 2.0 mm Kirschner wire is used to temporarily retain the reduction. SSP split is repairedFig. 12Intraoperative fluoroscopy. Anteroposterior (**a**) and axial (**b**) fluoroscopic radiographs. *White arrows* indicate the allograftFig. 13Plate attachment. Finally, an appropriately sized proximal humerus locking plate is attached directly lateral to the bicipital groove and temporarily fixed using a cortical screw in the gliding hole and two Kirschner wires. Using the fluoroscope, the plate is adjusted and positionedFig. 14Definitive plate fixation. At least six locking head screws, including A and E levels (if at all possible to maximize the screws' lever arm), and three bicortical shaft screws are inserted. Optionally, the functional components of the rotator cuff may be secured and knotted to the plate. Lateral (**a**) and anteroposterior (**b**) views. Allograft and humeral head highlighted translucently for better visualizationFig. 15Anteroposterior (**a1, b1, c1**) and lateral (**a2, b2, c2**) schematic drawings of the preoperative (**a1,2**), intraoperative (**b1,2**), and postoperative (**c1,2**) proximal humerus. Pink "mushroom" indicating the structural allograft and its positioning within the proximal humerus in **b1,2**, and **c1,2**Fig. 16Radiological documentation. Anteroposterior (**a**) and axial (**b**) fluoroscopic views are obtained to document the proper position of the allograft and the fracture reduction. After copious lavage and hemostasis, the skin is closed in layers (subcutaneously and the skin itself, additional closure of deep structures like muscles or fascias is not recommended). Adhesive dressing, shoulder sling until interscalene block is dissolved, and for comfort afterwards (see Fig. [15](#Fig15){ref-type="fig"} for details). Anteroposterior (**a**) and axial (**b**) fluoroscopic radiographs, intra- (post-)operatively. *White arrows* indicate allograftFig. 17Postoperative shoulder fixation. Shoulder sling for comfort

Postoperative management {#Sec12}
========================

Removal of stitches after 12--14 daysCryotherapy as needed during inpatient careAnti-inflammatory medication on demandShoulder sling for comfortActive assisted to active full ROM, as toleratedInpatient postoperative anteroposterior (ap), outlet view (ov), and Velpeau view radiographsClinical and radiological follow-ups (FU):Week 6: clinical FU, ap, ov, and ax (as tolerated) radiographsMonths 3, 6, and 12: clinical FU, ap, ov, and ax radiographs

Errors, hazards, complications {#Sec13}
==============================

Allograft cut too small: use of the cut parts as additional bony putty around the graft to achieve a press fitting construct prior to definitive fixationInfection of the allograft: indication for surgery and explantation of the graft; implantation of a spacer, several surgical re-looks as needed, and priming for the definitive procedure (i. e., implantation of an antibiotic loaded allograft; prosthesis)

Results {#Sec14}
=======

Methods {#Sec15}
-------

Retrospective case series between July 2009 and November 2011 (Tab. [1](#Tab1){ref-type="table"}; \[[@CR1]\])Cancellous allograft was used to augment plate fixation of the fracturesInclusion criteriaVarus displaced two-part fracture (AO A2.2; \>45°, unstable eroding subsidence, impression of the shaft into the head)Interval between injury and surgery between 1 and 8 weeks following an initial trial of conservative treatmentImplantation of a structural bony allograftHigh-risk patientPatient noncompliance

###### 

Patients demographics and concomitant diseases

  Patient no.   Gender   Age (years)   Dominant arm injured   BMI    Varus angle pre-op (°)   Follow up (months)   Risk factors         ASA score   Comments
  ------------- -------- ------------- ---------------------- ------ ------------------------ -------------------- -------------------- ----------- ---------------------------------------
  1             F        73            No                     22.5   50                       36                   CA, CT, OP, MA       3           Pulmonary emphysema, breast cancer
  2             F        62            Yes                    34.6   46                       24                   CA, CT, MD           4           Seizures
  3             F        78            No                     22.2   45                       27                   CA, OP, DM           4           Pancreatitis
  4             F        67            Yes                    20.8   51                       29                   CA, OP               2           
  5             F        52            Yes                    24.1   52                       48                   CT, CA, OP, PI       2           
  6             M        57            Yes                    38.1   45                       36                   DE, DM, AH           3           Plexus injury (resolved)
  7             M        67            No                     21.1   57                       41                   CA, CT, DM, AH, CL   3           Chronic liver disease (Child--Pugh B)
  8             F        64            Yes                    25.3   58                       25                   CA, OP, DM           3           
  9             F        56            Yes                    27.5   59                       28                   CT, PI               3           
  10            F        62            Yes                    21.2   46                       24                   CA, PE, DM           3           Polyarthritis
  Median                 63.0                                 23.3   50.5                     28.5                                      3           

*ASA* American Society of Anesthesiologists; *Pre-op* preoperative; *CA* chronic alcohol abuse; *CT* chronic tobacco abuse; *OP* osteoporosis; *MA* malignoma; *MD* multiple drug abuse (psychotropics); *PI* psychotic illness; *DE* severe depression; *AH* arterial hypertension; *CL* fibrotic or cirrhotic liver disease, *BMI* body mass index

Outcomes {#Sec16}
--------

Median follow-up 28.5 months (Tab. [2](#Tab2){ref-type="table"})Nine of 10 fractures healed with incorporation of the bony allograftsNo systemic or local complicationsNo significant loss of reduction or evidence of avascular necrosis of the humeral headMedian Constant--Murley score 72.0 (range 45--86)Median pain on the visual analog scale 1 (range 0--7)Median ROM:Flexion 155° (range 90--170°), abduction 168° (range 95--180°), external rotation 43° (range 30--50°)Flexion −13 %, abduction −14 %, external rotation −15 %, compared to the uninjured contralateral sideMedian abduction power 64 % of the uninjured sideMedian varus displacement 51° (range 45--59°) preoperatively, 4° (range −5 to 19°) intraoperatively, 13° (range 1--18°) at the time of the final follow-upImprovement of 38°

###### 

Individual results

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Patient\   Constant--Murley score   Pain (VAS)   Time to surgery (weeks)   Follow-up (months)   Flexion (°)   Bony union   Abduction (°)   External rotation (°)   Abduction power (% of uninjured side)   Varus angle intra-op (°)   Varus angle post-op (°)
  no.                                                                                                                                                                                                                                   
  ---------- ------------------------ ------------ ------------------------- -------------------- ------------- ------------ --------------- ----------------------- --------------------------------------- -------------------------- -------------------------
  1          83                       0            1                         36                   170           Yes          120             50                      79                                      15                         16

  2          48                       4            2                         24                   90            Yes          90              45                      63                                      2                          9

  3          84                       0            3                         27                   170           Yes          120             50                      89                                      10                         18

  4          64                       2            3                         29                   140           Yes          100             35                      67                                      5                          15

  5          86                       0            1                         48                   170           Yes          120             50                      53                                      19                         21

  6          84                       0            6                         36                   160           Yes          110             40                      58                                      0                          5

  7          45                       7            2                         41                   130           No           80              30                      100                                     −5                         --

  8          80                       0            6                         25                   160           Yes          120             50                      43                                      −3                         11

  9          55                       5            7                         28                   140           Yes          80              35                      39                                      5                          7

  10         58                       2            8                         24                   150           Yes          90              40                      40                                      3                          14

  Median     72.0                     1            3.0                       28.5                 155                        105             43                      60.5                                    4                          12.5
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*VAS* Visual Analog Scale; *Intra-op* intraoperative; *Post-op* postoperative
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